TNF-targeted therapies, however, have largely failed in the treatment of neurological diseases, possibly due to the often-antithetic functions of the two TNF receptors and, importantly, to the limited knowledge regarding the exact contribution of microglial TNFR2 signaling after CNS injury. Here, TNFRSF1B is linked to nervous system disorder.